The law firm has been growing its PE funds team, which advised on 150 secondaries deals worth $17.5bn in 2019.
1 min read · 14 April 2021
The listed firm brought the launch of Strategic Equity IV forward by two years due to faster-than-expected deployment.
2 min read · 13 April 2021
This is at least the second appointment Goldman’s financial sponsors M&A group has made from Lazard after the appointment of MD Alex Mejia who will start in May.
2 min read · 12 April 2021
The deals are increasingly seen as an alternative to exit and will drive activity in Asia-Pacific say Greenhill’s Briac Houtteville and Lloyd Bradbury.
5 min read · 08 April 2021
A positive selection bias, deep due diligence and strong alignment make GP-led secondaries an attractive proposition, write managing directors Brian Mooney and Stephen Sloan in this sponsored Q&A.
5 min read · 07 April 2021
The top-level hire will work with co-head Michael Woolhouse to build out the firm’s secondaries team, Secondaries Investor has learned.
2 min read · 06 April 2021
The appetite for recapitalisations of small numbers of high-performing assets is adding opportunities (and challenges) to the GP-led market, say Travers Smith partner Sam Kay and senior associate Ed Ford.
6 min read · 06 April 2021
The buyout shop is making a €300m investment from its latest fund in the process, which values Springer Nature at about $7bn.
2 min read · 06 April 2021
Innovation should drive the continued growth of the GP-led secondaries market, write Nigel Dawn and Ryan Rohloff in this sponsored article.
4 min read · 01 April 2021